Quantcast

Latest heart diseases Stories

2014-07-23 16:28:13

Innovative Technology Adds To Company's Leading Portfolio of Treatment Options for Coronary Artery Disease MARLBOROUGH, Mass., July 23, 2014 /PRNewswire/ -- Continuing to advance the development of innovative treatment options for coronary artery disease, Boston Scientific Corporation (NYSE: BSX) has received CE Mark and begun the European market launch of the Agent(TM) Paclitaxel-Coated PTCA Balloon Catheter. The Agent Drug-Coated Balloon (DCB) provides physicians with an...

2014-07-07 08:26:07

LONDON, July 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Cardiac Resynchronization Therapy (CRT) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018http://www.reportbuyer.com/pharma_healthcare/medical_devices/cardiac_resynchronization_therapy_crt_devices_emerging_markets_brazil_russia_india_china_south_africa_south_korea_2009_2015.html Global Market Watch:BRICSS Cardiac Resynchronization Therapy...

healthy lifestyle reverses heart disease risk
2014-07-01 05:33:20

redOrbit Staff & Wire Reports - Your Universe Online Eliminating unhealthy habits such as losing weight and kicking the cigarette habit in your 30s and 40s could potentially reverse the natural progression of coronary artery disease, according to new research appearing in the June 30 edition of the journal Circulation. According to lead investigator Bonnie Spring, a professor of preventive medicine at the Northwestern University Feinberg School of Medicine, and her colleagues,...

2014-06-24 08:32:14

Pioneering Angiogenic Gene Therapy for the Potential Treatment of Millions of Patients with Heart Disease Worldwide SAN DIEGO, June 24, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) will report today at the Biotechnology Industry Organization's 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx(®) Ad5FGF-4, Cardium Therapeutics' angiogenic gene...

2014-06-10 23:00:30

Yesterday, on Monday, June 9, 2014, the Oklahoma Heart Hospital, and The Ohio State University implanted the United States’ first miniaturized, wireless monitoring sensors to manage heart failure (HF). The CardioMEMS HF System is the first and only FDA-approved heart failure monitoring device that has been proven to significantly reduce hospital admissions when used by physicians to manage heart failure. Oklahoma City (PRWEB) June 10, 2014 The CardioMEMS HF System features a sensor that...

How Does High Blood Pressure In Middle Age May Affect Memory In Old Age?
2014-06-05 03:58:30

American Academy of Neurology New research suggests that high blood pressure in middle age plays a critical role in whether blood pressure in old age may affect memory and thinking. The study is published in the June 4, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology. "Our findings bring new insight into the relationship between a history of high blood pressure, blood pressure in old age, the effects of blood pressure on brain structure, and...

2014-06-04 14:50:47

Duke University Medical Center Implantable cardioverter defibrillators (ICDs) are associated with improved survival among heart failure patients whose left ventricles only pump 30 to 35 percent of blood out of the heart with each contraction, according to a study from the Duke Clinical Research Institute. The findings, published in the June 4 issue of the Journal of the American Medical Association, support existing recommendations to implant ICDs in patients with a left ventricular...

2014-06-02 12:28:51

ATLANTA, June 2, 2014 /PRNewswire/ -- Arcapita Ventures announced today that CardioMEMS, Inc. has been acquired by St. Jude Medical, Inc. (NYSE: STJ) a global medical device company headquartered in St. Paul, MN. St. Jude Medical had previously invested $60 million for 19 percent ownership of CardioMEMS and has now exercised its exclusive option to purchase the remaining 81 percent of the company in a transaction valued in excess of $450 million. CardioMEMS, Inc., an Atlanta-based...

2014-05-29 23:12:02

Home Care Assistance – Greater Toronto (http://www.GreaterTorontoHomeCare.ca), the area’s leading provider of non-medical, in-home senior care, is releasing its advice on the best and safest practices for rehabilitating after experiencing a heart attack, congestive heart failure, or one of many other cardiovascular conditions. Toronto, Canada (PRWEB) May 29, 2014 Home Care Assistance – Greater Toronto (http://www.GreaterTorontoHomeCare.ca), the area’s leading provider of...

2014-05-29 12:25:40

Heart Failure Remains an Area of Focus for Physicians, Facilities and Manufacturers, According to Findings from Decision Resources Group BURLINGTON, Mass., May 29, 2014 /PRNewswire/ -- Decision Resources Group finds that the U.S. cardiac assist device market has gained traction in recent years with product innovations, particularly among ventricular assist devices (VADs), commonly known in the media as LVADs. There are currently limited treatment options for patients with acute heart failure...


Latest heart diseases Reference Libraries

Cardiac Stress Test
2012-11-18 19:30:13

The cardiac stress test is a diagnostic test used in Cardiac pathology for the purpose of patient diagnosis. It measures the heart’s function while placing a heavier workload on the heart. The cardiologist cannot be at the patient’s side while at work, under stress, during a workout or pushed to the limit so this test mimics those activities in a controlled setting. How it is Performed The stress is created by increasing the workload on the cardiac system. This can be accomplished by...

More Articles (1 articles) »
Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related